Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement

Purdue Pharma and the Sackler family—the makers of OxyContin—have finally struck a deal with all U.S. states and territories, agreeing to pay $7.4 billion to settle claims over their role in fueling the opioid crisis. This ends years of legal battles, though critics argue the Sacklers themselves are still shielded from personal liability.